安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Immunis
Immunis AI is a privately held company committed to making a global impact by empowering patients and their physicians with actionable information for disease management Our patented platform leverages the body’s own immune defense system, state of the art analytical methods, and AI machine learning to provide unique real-time insights
- Immunis Inc. Secures $25 Million Funding for Stem Cell-Derived . . .
Immunis Inc , a pioneering clinical-stage biotechnology company focused on developing stem cell-derived secretome therapies, has successfully raised $25 million in its latest funding round
- Immunis Announces First-in-Human Injection of Secretome Product for Age . . .
Immunis is a private biotechnology company developing a novel immunomodulatory secretome product for the various manifestations of age and disease-related immune decline
- Immunis Closes $10 Million Financing Round - BioSpace
Immunis Inc , a private biotechnology company developing a novel treatment for age and disease-related immune decline, has closed a $10M Series A First Closing financing led by Remiges Ventures with participation by several other healthcare investment firms
- Keirstead’s Immunis Gets FDA Ok for Phase 2 Trial
Irvine-based biotechnology startup Immunis Inc recently received approval from the Food and Drug Administration to start Phase 2 of a clinical trial for its investigational drug Immuna, which claims to reduce fat while preserving muscle
- Immunis | immune decline, age-related diseases, Zoonop
Immunis operates a business model focused on research and development of biotechnology products aimed at redefining age-associated immune treatment Their investigative product line emphasizes naturally sourced secretomes, showcasing significant promise in pre-clinical trials
- Multi-active Biologics for Immune and Age-related Diseases - Immunis, Inc.
Immunis developed a novel method to grow human cells for clinical use and direct them to become highly pure populations of defined cells that secrete hundreds of all-natural factors Our technology captures these powerful multi-active biologics to produce an investigational therapy called IMM01-STEM
|
|
|